Home / Stocks / EWTX

EWTX insider trading

Edgewise Therapeutics, Inc. — open-market insider buys and $1M+ sells from SEC Forms 3, 4 and 5.
Insider buys · 24 mo
3
Bought · 24 mo
$20.2M
Buys · last 90 days
0 · $0
Most recent buy
2025-11-13

Recent insider filings

FiledInsiderTypeSharesPriceValue
2026-07-02Russell Alan J
Chief Scientific Officer
Sold200,000$39.41$7.9M
2026-05-05Donovan Joanne M.
CMO
Sold50,000$38.57$1.9M
2026-01-23Edris Badreddin
Director
Sold66,477$29.44$2.0M
2025-11-13Fox Jonathan C
Director
Bought10,700$18.64$199k
2025-11-13Russell Alan J
Chief Scientific Officer
Sold100,000$21.12$2.1M
2025-08-28Russell Alan J
Chief Scientific Officer
Sold100,000$14.60$1.5M
2025-04-04Thompson Peter A.
Director · 10% owner
Bought496,771$20.13$10.0M
2025-04-04ORBIMED ADVISORS LLC
Director · 10% owner
Bought496,771$20.13$10.0M
2024-12-31Russell Alan J
Chief Scientific Officer
Sold100,000$27.37$2.7M
2024-09-24Russell Alan J
Chief Scientific Officer
Sold74,185$28.25$2.1M
2024-09-24MOORE JOHN R
General Counsel
Sold50,000$28.37$1.4M
2024-09-24Derakhshan Behrad
Chief Business Officer
Sold42,068$29.03$1.2M
2024-09-24Carruthers R Michael
Chief Financial Officer
Sold96,068$28.57$2.7M

Most active insider buyers

InsiderRoleBuysTotal bought
Thompson Peter A.Director · 10% owner1$10.0M
ORBIMED ADVISORS LLCDirector · 10% owner1$10.0M
Fox Jonathan CDirector1$199k

See EWTX on the chart

Every insider buy and sell for EWTX plotted on the price, the full two-year history, cluster scores and daily updates — in the members area, $29/month. A free quarterly sample of the whole dataset needs no account.

Open the browserFree sample
Data from the SEC EDGAR ownership filings, refreshed daily. Only open-market purchases (transaction code P) and sales of $1M or more are shown; grants, option exercises and tax withholding are excluded because they run on schedules set years earlier. Not investment advice.